K. D. Wiedey

No ORCID on file · 2 papers in corpus
rct 2001
Climacteric : the journal of the International Menopause Society ·doi:10.1080/713605132

OBJECTIVE: To evaluate the efficacy, safety and tolerability of continuous combined hormone replacement therapy (HRT) with Climodien (estradiol valerate 2 mg plus dienogest 2 mg). DESIGN: Open, multinational, multicenter, non-controlled ph…

nonrandomized-trial 2001
·doi:10.1080/cmt.4.4.332.342

Objective To evaluate the efficacy, safety and tolerability of continuous combined hormone replacement therapy (HRT) with Climodien® (estradiol valerate 2 mg plus dienogest 2 mg). Design Open, multinational, multicenter, non-controlled phas…